Patching Retinal Breaks with Chitosan for Retinal Detachment in Rabbits.

IF 2 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Qingquan Wei, Yanyun Jiang
{"title":"Patching Retinal Breaks with Chitosan for Retinal Detachment in Rabbits.","authors":"Qingquan Wei,&nbsp;Yanyun Jiang","doi":"10.24976/Discov.Med.202335176.30","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Rhegmatogenous retinal detachment (RRD) is caused by one or more full-thickness retinal breaks. The current RRD treatments have several drawbacks. Chitosan is one of the most commonly used natural polymers for wound healing and has been demonstrated to be biodegradable, biocompatible, non-toxic, bioadhesive, and bioactive. This study aimed to determine the reliability and effectiveness of chitosan for sealing retinal breaks in rabbits.</p><p><strong>Methods: </strong>Eighteen blue purple rabbits were randomly divided into three groups: chitosan (n = 6), RRD (n = 6), and control (n = 6). The RRD model was established using vitrectomy, making retinal holes, and subretinal fluid injection in the RRD and chitosan groups. One week after the establishment of the model, chitosan was applied within the range of the holes in the chitosan group, and the vitreous body was filled with perfusion fluid. Except the chitosan treatment, the RRD group underwent the same procedure. Intraocular pressure (IOP) measurement, fundus photography, B-mode ultrasound, optical coherence tomography (OCT), histology, and enzyme linked immunosorbent assay (ELISA) were performed.</p><p><strong>Results: </strong>Retinas of all eyes in the RRD group were detached, whereas those of all eyes in the chitosan group remained attached. The concentrations of epidermal growth factor (EGF), fibroblast growth factor (FGF)-2, transforming growth factor β (TGF-β), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and IL-8 in the vitreous fluid of the RRD group were significantly higher than those of the control group (<i>p</i> < 0.05). Furthermore, the concentrations of EGF, FGF-2, TGF-β, and VEGF in the vitreous fluid of the chitosan group were higher compared to those of the RRD group (<i>p</i> < 0.05), whereas the concentrations of IL-6 and IL-8 were lower (<i>p</i> < 0.05).</p><p><strong>Conclusions: </strong>Chitosan may be a reliable method for sealing retinal breaks. Moreover, chitosan can maintain high levels of growth factors and reduce inflammatory factors in the vitreous, which may reduce and delay the death of retinal cells and help restore visual function after retinal repositioning.</p>","PeriodicalId":11379,"journal":{"name":"Discovery medicine","volume":"35 176","pages":"293-299"},"PeriodicalIF":2.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discovery medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24976/Discov.Med.202335176.30","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Rhegmatogenous retinal detachment (RRD) is caused by one or more full-thickness retinal breaks. The current RRD treatments have several drawbacks. Chitosan is one of the most commonly used natural polymers for wound healing and has been demonstrated to be biodegradable, biocompatible, non-toxic, bioadhesive, and bioactive. This study aimed to determine the reliability and effectiveness of chitosan for sealing retinal breaks in rabbits.

Methods: Eighteen blue purple rabbits were randomly divided into three groups: chitosan (n = 6), RRD (n = 6), and control (n = 6). The RRD model was established using vitrectomy, making retinal holes, and subretinal fluid injection in the RRD and chitosan groups. One week after the establishment of the model, chitosan was applied within the range of the holes in the chitosan group, and the vitreous body was filled with perfusion fluid. Except the chitosan treatment, the RRD group underwent the same procedure. Intraocular pressure (IOP) measurement, fundus photography, B-mode ultrasound, optical coherence tomography (OCT), histology, and enzyme linked immunosorbent assay (ELISA) were performed.

Results: Retinas of all eyes in the RRD group were detached, whereas those of all eyes in the chitosan group remained attached. The concentrations of epidermal growth factor (EGF), fibroblast growth factor (FGF)-2, transforming growth factor β (TGF-β), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), and IL-8 in the vitreous fluid of the RRD group were significantly higher than those of the control group (p < 0.05). Furthermore, the concentrations of EGF, FGF-2, TGF-β, and VEGF in the vitreous fluid of the chitosan group were higher compared to those of the RRD group (p < 0.05), whereas the concentrations of IL-6 and IL-8 were lower (p < 0.05).

Conclusions: Chitosan may be a reliable method for sealing retinal breaks. Moreover, chitosan can maintain high levels of growth factors and reduce inflammatory factors in the vitreous, which may reduce and delay the death of retinal cells and help restore visual function after retinal repositioning.

壳聚糖修补兔视网膜裂孔治疗视网膜脱离。
背景:孔源性视网膜脱离(RRD)是由一个或多个全层视网膜断裂引起的。目前的RRD治疗有几个缺点。壳聚糖是最常用的用于伤口愈合的天然聚合物之一,已被证明具有可生物降解、生物相容性、无毒、生物粘附和生物活性。本研究旨在确定壳聚糖在兔视网膜破裂愈合中的可靠性和有效性。方法:18只蓝紫色家兔随机分为壳聚糖组(n = 6)、RRD组(n = 6)和对照组(n = 6), RRD组和壳聚糖组分别采用玻璃体切除、视网膜穿孔、视网膜下液注射等方法建立RRD模型。模型建立1周后,壳聚糖组在孔洞范围内施用壳聚糖,玻璃体内灌注灌注液。除壳聚糖处理外,RRD组采用相同的处理方法。进行眼内压(IOP)测量、眼底摄影、b超、光学相干断层扫描(OCT)、组织学检查和酶联免疫吸附试验(ELISA)。结果:RRD组全眼视网膜脱离,壳聚糖组全眼视网膜保持附着。RRD组玻璃体液中表皮生长因子(EGF)、成纤维细胞生长因子(FGF)-2、转化生长因子β (TGF-β)、血管内皮生长因子(VEGF)、白细胞介素-6 (IL-6)、IL-8浓度显著高于对照组(p < 0.05)。壳聚糖组玻璃体液中EGF、FGF-2、TGF-β和VEGF的浓度高于RRD组(p < 0.05), IL-6和IL-8的浓度低于RRD组(p < 0.05)。结论:壳聚糖是一种可靠的治疗视网膜破裂的方法。此外,壳聚糖可以维持玻璃体中高水平的生长因子和减少炎症因子,从而减少和延缓视网膜细胞的死亡,有助于恢复视网膜重新定位后的视觉功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Discovery medicine
Discovery medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.40
自引率
0.00%
发文量
80
审稿时长
6-12 weeks
期刊介绍: Discovery Medicine publishes novel, provocative ideas and research findings that challenge conventional notions about disease mechanisms, diagnosis, treatment, or any of the life sciences subjects. It publishes cutting-edge, reliable, and authoritative information in all branches of life sciences but primarily in the following areas: Novel therapies and diagnostics (approved or experimental); innovative ideas, research technologies, and translational research that will give rise to the next generation of new drugs and therapies; breakthrough understanding of mechanism of disease, biology, and physiology; and commercialization of biomedical discoveries pertaining to the development of new drugs, therapies, medical devices, and research technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信